<div id="readability-page-1"><p>J.P. Morgan analyst Brian Essex maintained a Buy rating on Cellebrite DI today and set a price target of $24.00.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>According to TipRanks, Essex is a 5-star analyst with an average return of <span>11.3%</span> and a 57.14% success rate. Essex covers the Technology sector, focusing on stocks such as CrowdStrike Holdings, Fortinet, and JFrog.</p> <p>In addition to J.P. Morgan, Cellebrite DI also received a Buy from Needham’s Mike Cikos in a report issued today. However, on November 7, TR | OpenAI – 4o reiterated a Hold rating on Cellebrite DI (NASDAQ: CLBT).</p></div>

CLBT

<p>J.P. Morgan analyst Brian Essex maintained a Buy rating on Cellebrite DI with a $24.00 price target. Essex, a 5-star analyst, has an average return of 11.3% and a 57.14% success rate. Needham's Mike Cikos also issued a Buy rating, while TR reiterated a Hold rating on November 7.</p>

Cellebrite DI (CLBT) Gets a Buy from J.P. Morgan